174
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

2-5A Ligands—A New Concept for the Treatment of Prostate Cancer

, , , , &
Pages 1471-1477 | Published online: 05 Dec 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xinning Wang, Haibin Tian, Zhenghong Lee & WarrenD. W. Heston. (2012) Structure-Activity Relationships of 2′,5′-Oligoadenylate Analogue Modifications of Prostate-Specific Membrane Antigen (PSMA) Antagonists. Nucleosides, Nucleotides & Nucleic Acids 31:5, pages 432-444.
Read now

Articles from other publishers (5)

Emilia Kiuru, Suvi Malmikare & Mikko Ora. (2017) Synthesis and Deprotection of Biodegradably and Thermally Protected Dinucleoside-2′,5′-Monophosphate Prodrug Model of 2-5A. Chemistry & Biodiversity 14:9, pages e1700220.
Crossref
Xinning Wang, Steve S. Huang, Warren D.W. Heston, Hong Guo, Bing-Cheng Wang & James P. Basilion. (2014) Development of Targeted Near-Infrared Imaging Agents for Prostate Cancer. Molecular Cancer Therapeutics 13:11, pages 2595-2606.
Crossref
Steve S. Huang, Xinning Wang, Yuqing Zhang, Aniruddha Doke, Frank P. DiFilippo & Warren D. Heston. (2014) Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker. The Prostate 74:7, pages 702-713.
Crossref
Emilia Kiuru, Mikko Ora, Leonid Beigelman, Lawrence Blatt & Harri Lönnberg. (2012) Synthesis and Enzymatic Deprotection of Fully Protected 2′-5′ Oligoadenylates (2-5A): Towards a Prodrug Strategy for Short 2-5A. Chemistry & Biodiversity 9:4, pages 669-688.
Crossref
Emilia Kiuru, Mikko Ora, Leonid Beigelman, Lawrence Blatt & Harri Lönnberg. (2011) Synthesis and Enzymatic Deprotection of Biodegradably Protected Dinucleoside‐2′,5′‐monophosphates: 3‐(Acetyloxy)‐2,2‐bis(ethoxycarbonyl)propyl Phosphoesters of 3′‐ O ‐(Acyloxymethyl)adenylyl‐2′,5′‐adenosines . Chemistry & Biodiversity 8:2, pages 266-286.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.